It is an exciting period for the clinical management of multiple sclerosis (MS), with an expanding treatment landscape and recent approval of new disease-modifying therapies (DMTs) for both relapsing and progressive MS.  To keep clinicians up-to-date on these advancements, CME Outfitters presents a 3-part series of podcasts that examine and translate the emerging data on multiple sclerosis to practice. Earn credit on-the-go and in just minutes with these informative podcasts.

Biomarkers for Diagnosis and Prognosis of MS

Participate Now Annual meetings are avenues for the release of cutting-edge research findings, clinical advances in the diagnosis and management of MS, and emerging care issues, as well as new MS practice trends, innovative care practices, and health policy issues affecting access to care. However, community clinicians are often unable to attend due to busy schedules and patient loads. As it is critical that neurologists involved in the care of patients with MS learn how to evaluate and apply the latest advances, this series of podcasts examines and translates the emerging data to practice. In the first episode, Dr. Aaron Miller identifies and presents the most important information on diagnostic modalities and biomarkers as tools to guide clinical decision-making.

Navigating Current and Emerging MS Therapies – What Does the Evidence Say?

Participate Now The second episode of this MS CMEOcast series will cultivate the latest evidence presented at a renowned 2019 MS annual meeting on the safety and efficacy of current and emerging therapies for relapsing and progressive MS, with a goal of translating these findings to treatment decisions that optimize the care of patients with MS.

Translating Evidence into an Individualized Treatment Plan in Patients with MS

Participate Now New practice trends and innovative care practices were recently presented at a renowned 2019 MS annual meeting, however, many busy community clinicians were not able to attend. To share these valuable updates with the MS community, the final episode of this series highlights the latest clinical evidence supporting individualized strategies for optimal treatment selection and switching in patients with MS.

Meet the Expert

Aaron Miller, MD, FAAN, FANA
Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Professor and Vice-Chair for Education
Department of Neurology
Icahn School of Medicine at Mount Sinai
New York, NY